Fentanyl Transdermal Patch With CHADD™ for Breakthrough Pain in Patients With Moderate to Severe Non-Malignant Pain

This study has been terminated.

(Difficulty identifying and enrolling eligible patients)

Sponsor:

Information provided by (Responsible Party):

ZARS Pharma Inc.

ClinicalTrials.gov Identifier:

NCT00278824

First received: January 16, 2006

Last updated: June 4, 2012

Last verified: June 2012

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study has been terminated.
Study Completion Date:	August 2006
Primary Completion Date:	August 2006 (Final data collection date for primary outcome measure)